source
- Analysts zero in on three Bristol Myers programs as company gears up for multiple data readouts through 2026Analysts are closely watching Bristol Myers Squibb's pipeline, focusing on three key programs that could drive growth in the coming years. Wall Street expects a flurry of data readouts, with at le…
- XTL Bio to acquire Psyga Bio, adding psychedelic manufacturing capabilityXTL Bio announced it will acquire all outstanding shares of Psyga Bio, a biotech focused on psychedelic therapies. The transaction gives XTL access to Psyga’s manufacturing facility, expanding its…